BELITE BIO INC - AMERICAN DEPOSITARY SHARES

48.60

08-July-24 15:59:47

15 minutes delayed

Stocks

+3.10

+6.81%

Today's range

45.70 - 49.10

ISIN

N/A

Source

NASDAQ

Belite Bio Reports First Half 2022 Operational Highlights and Financial Results

10 Aug 2022 21:51:10 By Nasdaq GlobeNewswire
Belite Bio to Host Conference Call on August 11, 2022 to Discuss First Half 2022 Financial Results

01 Aug 2022 16:10:00 By Nasdaq GlobeNewswire
Belite Bio Submits Investigational New Drug (IND) Application to FDA for Approval to Proceed with LBS-008 Phase 3 Clinical Trial for the Treatment of Stargardt Disease

19 Jul 2022 16:05:33 By Nasdaq GlobeNewswire
Belite Bio Announces Partial Exercise of Over-Allotment Option in Initial Public Offering

12 May 2022 16:30:00 By Nasdaq GlobeNewswire
Belite Bio Presented Interim Results of LBS-008 Phase 1b/2 Study in Adolescent STGD1 at ARVO Annual Meeting 2022

05 May 2022 08:00:02 By Nasdaq GlobeNewswire
Belite Bio Announces Closing of $36 Million Initial Public Offering

03 May 2022 16:30:00 By Nasdaq GlobeNewswire
Belite Bio Receives FDA Fast Track Designation For LBS-008

03 May 2022 06:50:00 By Nasdaq GlobeNewswire

<<
<
1
2
3
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.